1-236226348-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000354619.10(ERO1B):āc.973A>Gā(p.Ile325Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000855 in 1,614,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000354619.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERO1B | NM_019891.4 | c.973A>G | p.Ile325Val | missense_variant | 12/16 | ENST00000354619.10 | NP_063944.3 | |
LOC124904561 | XR_007066961.1 | n.924+4463T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERO1B | ENST00000354619.10 | c.973A>G | p.Ile325Val | missense_variant | 12/16 | 1 | NM_019891.4 | ENSP00000346635 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000916 AC: 23AN: 251056Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135666
GnomAD4 exome AF: 0.0000629 AC: 92AN: 1461816Hom.: 0 Cov.: 31 AF XY: 0.0000550 AC XY: 40AN XY: 727214
GnomAD4 genome AF: 0.000302 AC: 46AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2022 | The c.973A>G (p.I325V) alteration is located in exon 12 (coding exon 12) of the ERO1B gene. This alteration results from a A to G substitution at nucleotide position 973, causing the isoleucine (I) at amino acid position 325 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at